ArticleJournal of the American Heart Association2025

Microbiota γ-Butyrobetaine Is Associated With Increased Risk of Major Adverse Limb Events in People With Lower Extremity Arterial Disease Undergoing Endovascular Therapy.

Zheng-Wei Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.